ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

CLIN Clinigen Group Plc

925.00
0.00 (0.00%)
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Clinigen Group Plc LSE:CLIN London Ordinary Share GB00B89J2419 ORD 0.1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 925.00 924.50 925.00 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

ODDO Meriten Asset Management Form 8.3 - CLINIGEN GROUP (6937R)

25/09/2017 10:00am

UK Regulatory


Clinigen (LSE:CLIN)
Historical Stock Chart


From Apr 2019 to Apr 2024

Click Here for more Clinigen Charts.

TIDMCLIN

RNS Number : 6937R

ODDO Meriten Asset Management

25 September 2017

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

   1.         KEY INFORMATION 
 
 (a) Full name of discloser:                                                         ODDO MERITEN ASSET MANAGEMENT SAS 
----------------------------------------------------------------------------------  ---------------------------------- 
 (b) Owner or controller of interests and short positions disclosed, if different 
 from 1(a): 
 The naming of nominee or vehicle companies is insufficient. For a trust, the 
 trustee(s), 
 settlor and beneficiaries must be named. 
----------------------------------------------------------------------------------  ---------------------------------- 
 (c) Name of offeror/offeree in relation to whose relevant securities this form      CLINIGEN GROUP 
 relates: 
 Use a separate form for each offeror/offeree 
----------------------------------------------------------------------------------  ---------------------------------- 
 (d) If an exempt fund manager connected with an offeror/offeree, state this and 
 specify identity 
 of offeror/offeree: 
----------------------------------------------------------------------------------  ---------------------------------- 
 (e) Date position held/dealing undertaken:                                          22/09/2017 
 For an opening position disclosure, state the latest practicable date prior to 
 the disclosure 
----------------------------------------------------------------------------------  ---------------------------------- 
 (f) In addition to the company in 1(c) above, is the discloser making disclosures   NO 
 in respect 
 of any other party to the offer? 
 If it is a cash offer or possible cash offer, state "N/A" 
----------------------------------------------------------------------------------  ---------------------------------- 
 
   2.         POSITIONS OF THE PERSON MAKING THE DISCLOSURE 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 
 Class of relevant security:                                                                   Common stock 
----------------------------------------------------------------------------------  ---------------------------------- 
                                                                                       Interests      Short positions 
----------------------------------------------------------------------------------  --------------  ------------------ 
                                                                                      Number    %     Number      % 
----------------------------------------------------------------------------------  ---------  ---  ---------  ------- 
 (1) Relevant securities owned and/or controlled:                                                    342 225    -0.30% 
--------------------------------------------------------------------------------------------------  ---------  ------- 
 (2) Cash-settled derivatives: 
----------------------------------------------------------------------------------  ---------  ---  ---------  ------- 
 (3) Stock-settled derivatives (including options) and agreements to 
 purchase/sell: 
----------------------------------------------------------------------------------  ---------  ---  ---------  ------- 
 
   TOTAL:                                                                                            342 225    -0.30% 
--------------------------------------------------------------------------------------------------  ---------  ------- 
 

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

   (b)        Rights to subscribe for new securities (including directors' and other employee options) 
 
 Class of relevant security in relation to which subscription right exists: 
---------------------------------------------------------------------------- 
 Details, including nature of the rights concerned and relevant percentages: 
---------------------------------------------------------------------------- 
 
   3.         DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

   (a)        Purchases and sales 
 
 Class of relevant security   Purchase/sale   Number of securities   Price per unit 
---------------------------  --------------  ---------------------  --------------- 
 Ordinary                     Sale (22/09)    6 101                  1057.358 GBp 
  Ordinary                     Sale (21/09)    25 715                 1046.714 GBp 
  Ordinary                     Sale (21/09)    9 809                  1050.043 GBp 
  Ordinary                     Sale (21/09)    70 875                 1035.90 GBp 
  Ordinary                     Sale (21/09)    8 075                  1051.456 GBp 
  Ordinary                     Sale (20/09)    10 125                 1030.89 GBp 
  Ordinary                     Sale (19/09)    405                    1019 GBp 
  Ordinary                     Sale (18/09)    3 916                  1039.529 GBp 
  Ordinary                     Sale (18/09)    810                    1039.20 GBp 
  Ordinary                     Sale (15/09)    351                    1041.36 GBp 
  Ordinary                     Sale (15/09)    818                    1044.023 GBp 
  Ordinary                     Sale (15/09)    13 217                 1026.80 GBp 
  Ordinary                     Sale (14/09)    21 133                 1051.089 GBp 
  Ordinary                     Sale (13/09)    19000                  1089.38 GBp 
  Ordinary                     Sale (13/09)    10 125                 1097.946 GBp 
  Ordinary                     Sale (13/09)    141 750                1083.53 GBp 
  Ordinary 
  Ordinary 
---------------------------  --------------  ---------------------  --------------- 
 
 
 
    (b)       Cash-settled derivative transactions 
 
    Class of relevant       Product description      Nature of dealing         Number of reference      Price per unit 
         security                 e.g. CFD         e.g. opening/closing a           securities 
                                                    long/short position, 
                                                   increasing/reducing a 
                                                    long/short position 
-------------------------  --------------------  -------------------------  -------------------------  --------------- 
 
 
   (c)        Stock-settled derivative transactions (including options) 
   (i)         Writing, selling, purchasing or varying 
 
   Class of       Product        Writing,      Number of       Exercise          Type       Expiry date   Option money 
   relevant     description    purchasing,     securities      price per         e.g.                        paid/ 
   security      e.g. call       selling,       to which         unit         American,                   received per 
                   option      varying etc.      option                        European                       unit 
                                                relates                          etc. 
-------------  -------------  -------------  -------------  --------------  -------------  ------------  ------------- 
 
 
   (ii)        Exercise 
 
   Class of relevant      Product description   Exercising/ exercised    Number of securities     Exercise price per 
        security            e.g. call option           against                                           unit 
-----------------------  --------------------  -----------------------  ---------------------  ----------------------- 
 
 
   (d)        Other dealings (including subscribing for new securities) 
 
 Class of relevant security         Nature of dealing          Details   Price per unit (if applicable) 
                               e.g. subscription, conversion 
---------------------------  -------------------------------  --------  ------------------------------- 
 
 
   4.         OTHER INFORMATION 
   (a)        Indemnity and other dealing arrangements 
 
 Details of any indemnity or option arrangement, or any agreement or understanding, formal 
  or informal, relating to relevant securities which may be an inducement to deal or refrain 
  from dealing entered into by the person making the disclosure and any party to the offer or 
  any person acting in concert with a party to the offer: 
  Irrevocable commitments and letters of intent should not be included. If there are no such 
  agreements, arrangements or understandings, state "none" 
--------------------------------------------------------------------------------------------- 
 
 
   (b)        Agreements, arrangements or understandings relating to options or derivatives 
 
 Details of any agreement, arrangement or understanding, formal or informal, between the person 
  making the disclosure and any other person relating to: 
  (i) the voting rights of any relevant securities under any option; or 
  (ii) the voting rights or future acquisition or disposal of any relevant securities to which 
  any derivative is referenced: 
  If there are no such agreements, arrangements or understandings, state "none" 
----------------------------------------------------------------------------------------------- 
 
 
   (c)        Attachments 
 
 Is a Supplemental Form 8 (Open Positions) attached?   NO 
----------------------------------------------------  --- 
 
 
 Date of disclosure:   25/09/2017 
--------------------  ---------------------------- 
 Contact name:         Corinne LEHR / Sophie SABRI 
                        +33 1 44 51 81 38 / 85 20 
--------------------  ---------------------------- 
                       Tanguy GOSSEIN 
                        +33 1 44 51 87 51 
--------------------  ---------------------------- 
 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS

The company news service from the London Stock Exchange

END

RETOKPDPFBKKBCB

(END) Dow Jones Newswires

September 25, 2017 05:00 ET (09:00 GMT)

1 Year Clinigen Chart

1 Year Clinigen Chart

1 Month Clinigen Chart

1 Month Clinigen Chart

Your Recent History

Delayed Upgrade Clock